Cita APA (7a ed.)

Lim, S., Baker, M., Derebail, V., Chaichian, Y., Genovese, M., Rao, P., . . . Tumlin, J. (2020). Phase II, randomised, double-blind, multicentre study evaluating the safety and efficacy of filgotinib and lanraplenib in patients with lupus membranous nephropathy. BMJ Publishing Group.

Cita Chicago Style (17a ed.)

Lim, Sam, et al. Phase II, Randomised, Double-blind, Multicentre Study Evaluating the Safety and Efficacy of Filgotinib and Lanraplenib in Patients with Lupus Membranous Nephropathy. BMJ Publishing Group, 2020.

Cita MLA (8a ed.)

Lim, Sam, et al. Phase II, Randomised, Double-blind, Multicentre Study Evaluating the Safety and Efficacy of Filgotinib and Lanraplenib in Patients with Lupus Membranous Nephropathy. BMJ Publishing Group, 2020.